7 results
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
RIPE Therapy - Drug ... - IDSA Guidelines ... #Tuberculosis ... #ActiveTB #RIPE ... #medications #pharmacology
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Resistant Tuberculosis ... #MDRTB #management ... #pharmacology # ... dosing #idsa #drugs
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... latent TB • Close ... RAL-based ART regimen ... #Treatment #management ... infections #HIVAIDS #pharmacology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... (LTBI) Pathophysiology ... inhibitors • Injection drug ... killed - rest LTBI ... TB #Diagnosis #Management
IDSA Summary of recommendations on drugs for use in a treatment regimen for patients with
multidrug-resistant tuberculosis,
IDSA Summary of ... recommendations on drugs ... in a treatment regimen ... #MDRTB #management ... antimicrobials #pharmacology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... (LTBI) Pathophysiology ... inhibitors • Injection drug ... killed - rest LTBI ... TB #Diagnosis #Management
Chloramphenicol - Antibiotics Class Overview

– 50S ribosomal inhibitor.   IV or PO (but PO form
beta-lactam allergy (has activity ... - A typical regimen ... beta-lactam allergy would ... several weeks after drug ... #Pharmacology #Antibiotics